← Back to Search

Insect-Derived Protein Supplements for Food Supplement Effect

N/A
Waitlist Available
Led By Keith Baar, PhD
Research Sponsored by University of California, Davis
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline (0 hour) to 90 minutes after supplementation
Awards & highlights

Study Summary

This trialwill test if insect-derived proteins can increase muscle protein synthesis and activate the mTORC1 pathway.

Who is the study for?
This trial is for healthy, active men and women with a normal weight (BMI between 18-25). Participants should not be on medications that could affect the study results or have health/diet restrictions impacted by protein supplements. Those allergic to shellfish are excluded due to potential allergy triggers in insect proteins.Check my eligibility
What is being tested?
The study tests if insect-derived proteins (IPC80 and Whole Buffalo Powder) can activate muscle cell growth pathways similarly to whey protein. Participants will consume these proteins, and their blood samples will be analyzed at various times to assess activation of mTORC1, a key regulator of muscle cell growth.See study design
What are the potential side effects?
Potential side effects may include digestive discomfort or allergic reactions, especially in individuals with shellfish allergies since similar allergens are present in mealworm-based products.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline (0 hour) to 90 minutes after supplementation
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline (0 hour) to 90 minutes after supplementation for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Muscle Proteins
Secondary outcome measures
mTORC1 activity

Trial Design

3Treatment groups
Experimental Treatment
Group I: Whole Buffalo PowderExperimental Treatment1 Intervention
This arm will be given a supplemental dose of Whole Buffalo Powder, an insect-derived protein source (0.25 g/kg body weight)
Group II: Whey proteinExperimental Treatment1 Intervention
This arm will be given a supplemental dose of whey protein (0.25 g/kg body weight)
Group III: IPC80Experimental Treatment1 Intervention
This arm will be given a supplemental dose of IPC80, an insect-derived protein source (0.25 g/kg body weight)
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Whey protein
2011
Completed Phase 4
~1180

Find a Location

Who is running the clinical trial?

University of California, DavisLead Sponsor
909 Previous Clinical Trials
4,704,110 Total Patients Enrolled
Keith Baar, PhDPrincipal InvestigatorUC Davis
5 Previous Clinical Trials
114 Total Patients Enrolled

Media Library

Whey protein Clinical Trial Eligibility Overview. Trial Name: NCT05457218 — N/A
Food Supplement Effect Research Study Groups: Whey protein, IPC80, Whole Buffalo Powder
Food Supplement Effect Clinical Trial 2023: Whey protein Highlights & Side Effects. Trial Name: NCT05457218 — N/A
Whey protein 2023 Treatment Timeline for Medical Study. Trial Name: NCT05457218 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What qualifications are required for prospective participants in this clinical experiment?

"This research project is currently seeking 20 volunteers aged between 18 and 30 to assess the impact of a food supplement. To be eligible, participants must possess good physical health (Body Mass Index ranging from 18-25 kg/m2) and identify as either male or female."

Answered by AI

Are there still openings for participants in this experiment?

"This medical trial is actively looking for participants. According to clinicaltrials.gov, the study was initially posted on October 1st 2022 and had its latest edit made 6 days later."

Answered by AI

What is the enrollment capacity for this clinical trial?

"Affirmative. The clinicaltrial.gov data confirms that this trial is actively accepting participants, having been initially posted on October 1st 2022 and lastly updated on the 6th of the same month. 20 individuals are sought across a single medical site."

Answered by AI

Does the study include individuals over 35 years old?

"The age boundary for enrollment in this research is between 18 and 30 years old, as outlined in the initial criteria."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Effect of Insect-derived Protein Supplements on Protein Synthesis and mTORC1 Activation
2022. "Effect of Insect-derived Protein Supplements on Protein Synthesis and mTORC1 Activation". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05457218.
~8 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top